Delivery Order SPE2DE23D0008-SPE2D625F4BNZ
Award Date 9/11/25
Potential Completion Date 9/25/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded Allergan USA Inc. a $2,814.00 fixed-price delivery order for Natrelle Inspira SCF 365CC breast implants with an ultimate completion date of August 22, 2025. This delivery order, issued on July 30, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle contracts valued at $13.5 million for Natrelle breast implants and surgical devices established in December 2022. The contract does not...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,425.00 for Natrelle Inspira SCM 560CC breast implants by the Defense Logistics Agency Medical Supply Chain, a Defense agency division. The award, issued on August 14, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The contract was awarded without set-aside designation, reflecting Allergan's status as a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on September 11, 2025, for Natrelle Inspira SCX 495CC breast implants, with a completion date of September 15, 2025. The contract was awarded without a set-aside designation and is being performed in Irvine, California. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, which oversees procurement of specialized medical devices for the Department of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $3,021 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SCF 415CC breast implants. The contract, which carries no set-aside designation, reflects Allergan's status as a sole-source provider of specialized reconstructive and aesthetic surgical devices to the federal government. The award is structured as a fixed-price contract with economic price adjustment, with performance...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source...